Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of sex steroid hormones on serotonin synthesis and degradation measured with PET
2015-000502-19Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- May 2016
- Modality
- Small Molecules, Peptides, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of estradiol, testosterone undecanoate, testosterone, cyproterone, triptorelin and 3 more in gender dysphoria (GD) (2 arms), sponsored by Medical University of Vienna. Primary endpoint: Net plasma-to-brain uptake constant (K*) for [11C]5-HTP. Started May 2016; status: completed.
02
Drugs
estradioltestosterone undecanoatetestosteronecyproteronetriptorelin
03
Conditions
gender dysphoria (GD)
Beyond the preview
Go deeper on 2015-000502-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000502-19.